Achyut Healthcare
- Market cap
- ₹ 165 Cr.
- P/E
- 776.2x
- P/B
- 4.56x
- 52-week range
- 4.7 – 10.04
- ROE
- 1%
- ROCE
- 1.2%
- Debt / equity
- 0.04
- Sector
- Pharmaceuticals & Biotechnology
- Industry
- Pharmaceuticals
- Listed on
- BSE
About
Achyut healthcare Limited is an India-based pharmaceutical trading company. The Company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The Company operates in the single business segment of pharmaceutical formulations in the form of tablets, capsules, oral liquid and injectable.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pharmaceuticals: 221 companies →Achyut Healthcare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)776.2 against a typical 34.3: pricier than most peers (1st = cheapest).218th of 220
- Sales growth+1.3% against a typical +15.6% from a year earlier.147th of 197
- Profit growth+40% against a typical +18.9% from a year earlier.61st of 160
- Share price, 3 months+16.4% against a typical −0.5%.46th of 200
- Size₹ 165.1 Cr. market value against a typical ₹ 507.7 Cr. (1st = largest).127th of 199
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 1 | 3 | 3 | 2 | 4 | 3 |
| Expenses | 0 | 1 | 3 | 2 | 2 | 4 | 3 |
| Operating Profit | −0 | 0 | 0 | 0 | −0 | 0 | 0 |
| OPM % | — | 5.4% | 2.3% | 3.1% | −0.6% | 0.5% | 5.8% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 20% | 7.7% | 9.1% | 31.3% | — | 0% | 26.3% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | 0 | 0.01 | 0 | 0.01 | 0 | 0 | 0.01 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 112%
- 3 Years
- 63%
- TTM
- 280%
- 10 Years
- —
- 5 Years
- 100%
- 3 Years
- 12%
- TTM
- −42%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 29%
- TTM
- —
- 10 Years
- —
- 5 Years
- 2%
- 3 Years
- 2%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Achyut Healthcare | ₹ 8.04 | ₹ 165 Cr. | 776.2x | 4.6x | 1% | — |
| Sun Pharmaceutical Industries | ₹ 1,743.00 | ₹ 4,18,194 Cr. | 38.9x | 5.6x | 14.2% | 19.1% |
| Divi's Laboratories | ₹ 8,984.00 | ₹ 2,38,497 Cr. | 74x | 11.6x | 16.2% | 24.3% |
| Torrent Pharmaceuticals | ₹ 4,482.00 | ₹ 1,70,475 Cr. | 76.4x | 20.2x | 27.1% | 15.3% |
| Cipla | ₹ 1,337.00 | ₹ 1,08,011 Cr. | 28x | 3.4x | 11.8% | 13.7% |
| Zydus Lifesciences | ₹ 1,127.85 | ₹ 1,12,503 Cr. | 21.3x | 4.3x | 19.7% | 18.5% |
Management
- Jigen Jagdishbhai Modi
- Chief Financial Officer, Managing Director, Executive Director
- Kaushalkumar Shrikrishnabhai Dave
- Company Secretary and Compliance Officer
- Amisha Jigen Modi
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.